Membrane Technological Pathways and Inherent Structure of Bacterial Cellulose Composites for Drug Delivery

Bioengineering (Basel). 2021 Dec 22;9(1):3. doi: 10.3390/bioengineering9010003.

Abstract

This report summarizes efforts undertaken in the area of drug delivery, with a look at further efforts made in the area of bacterial cellulose (BC) biomedical applications in general. There are many current methodologies (past and present) for the creation of BC membrane composites custom-engineered with drug delivery functionality, with brief consideration for very close applications within the broader category of biomedicine. The most emphasis was placed on the crucial aspects that open the door to the possibility of drug delivery or the potential for use as drug carriers. Additionally, consideration has been given to laboratory explorations as well as already established BC-drug delivery systems (DDS) that are either on the market commercially or have been patented in anticipation of future commercialization. The cellulose producing strains, current synthesis and growth pathways, critical aspects and intrinsic morphological features of BC were given maximum consideration, among other crucial aspects of BC DDS.

Keywords: bacterial cellulose; critical aspects; drug delivery systems; membrane technology; modification pathways.

Publication types

  • Review